Publicaciones (24) Publicaciones de ANA SUCH DÍAZ

2024

  1. Antibiotic stewardship programs in the Spanish emergency services: PROA-URG Study

    Revista Espanola de Quimioterapia, Vol. 37, Núm. 2, pp. 163-169

  2. Design of mobile and website health application devices for drug tolerability in hereditary fructose intolerance

    Orphanet Journal of Rare Diseases, Vol. 19, Núm. 1

2023

  1. Drug-related problems as reason for emergency department visit: 3 years of the FARM-URG registry

    International Journal of Pharmacy Practice, Vol. 31, Núm. 4, pp. 417-422

2022

  1. Increased Incidence of In-Hospital Ischemic Stroke During SARS-CoV-2 Outbreak: A Single-Center Study

    Neurocritical Care, Vol. 36, Núm. 1, pp. 208-215

  2. Reply letter to the editor concerning the article ‘Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance’

    Human Vaccines and Immunotherapeutics

2021

  1. Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study

    The Lancet Infectious Diseases, Vol. 21, Núm. 6, pp. 783-792

  2. Incidence of Thromboembolic Events in Cancer Hospitalized Patients With COVID-19

    Chest

  3. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis

    Journal of Thrombosis and Thrombolysis, Vol. 51, Núm. 1, pp. 40-46

  4. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study

    Thrombosis Research, Vol. 199, pp. 132-142

  5. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2020

  1. Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain

    Clinical Microbiology and Infection, Vol. 26, Núm. 11, pp. 1525-1536

  2. Drug exposure associated with exacerbation of symptoms in patients with myasthenia gravis

    Revista de Neurologia, Vol. 71, Núm. 4, pp. 143-150

2016

  1. Cross-cultural Adaptation and Validation of the Medication Regimen Complexity Index Adapted to Spanish

    Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 918-925

  2. Self-reported experience in patients treated with Hepatitis C direct acting antivirals

    Farmacia Hospitalaria, Vol. 40, Núm. 6, pp. 569-578

2014

  1. Encefalopatía hiperamonémica en un paciente tratado con 5-fluorouracilo

    Farmacia Hospitalaria

  2. Evaluación preventiva de riesgos en la incorporación de nuevos medicamentos a la práctica asistencial: Una propuesta metodológica

    Farmacia Hospitalaria, Vol. 38, Núm. 1, pp. 18-24

2013

  1. Drug prescribing in patients with renal impairment optimized by a computer-based, semi-automated system

    International Journal of Clinical Pharmacy, Vol. 35, Núm. 6, pp. 1170-1177

2012

  1. Papel del farmacéutico comunitario en el manejo de la hipertensión arterial

    Atencion Farmaceutica, Vol. 14, Núm. 2, pp. 108-115

  2. Papel del farmacéutico comunitario en el manejo de la hipertensión arterial

    Atención Farmacéutica, Vol. 14, Núm. 2, pp. 108-115

2011

  1. Desarrollo, implantación y evaluación de un programa de prescripción electrónica asistida de medicamentos en un hospital

    Trauma, Vol. 22, Núm. 2, pp. 137-142